The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Official Title: Prospective Collection of Plasma Samples From Patients Treated With Molecular Targeted Therapies for Squamous Cell Carcinoma of the Head and Neck
Study ID: NCT02139020
Brief Summary: The investigators will collect plasma samples at baseline, during treatment, and at progression.
Detailed Description: In this study, the investigators will collect plasma samples at baseline, during treatment, and at progression. This plasma bank will be used to study the potential value of some biomarkers to predict treatment activity or resistance to cetuximab or other targeted agents
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Clinique Saint-Pierre, Ottignies, Brabant Wallon, Belgium
Grand Hôpital de Charleroi, Charleroi, Hainaut, Belgium
Centre Hospitalier Jolimont-Lobbes-Nivelles-Tubize, Haine-Saint-Paul, , Belgium
CHU Liège, Liège, , Belgium
Clinique et Maternité Sainte-Elisabeth, Namur, , Belgium
Name: Jean-Pascal Machiels, MD, PhD
Affiliation: Cliniques universitaires Saint-Luc
Role: PRINCIPAL_INVESTIGATOR